Occurrence of acute megakaryoblastic leukemia in a patient with idiopathic growth hormone deficiency.
We describe a case of a 15 year old boy who developed acute megakaryoblastic leukemia (AMKL) while receiving treatment with human growth hormone (hGH) for idiopathic growth hormone deficiency (GHD). He was diagnosed as having idiopathic GHD and given hGH from December 1991. The examination of his peripheral blood showed mild pancytopenia 2 months before the start of the hGH therapy. Since January 1992, paleness of the skin, general fatigue and fervescence progressed gradually. In February 1992, because of the occurrence of acute leukemia, administration of hGH was discontinued. Judging from the results of surface marker analysis of the blast cells, the patient was diagnosed as having AMKL. He was treated with chemotherapy for acute non-lymphoblastic leukemia from March 1992. A complete remission was obtained after 4 weeks of treatment. The chemotherapy was completed in July 1993. He remains in complete remission 26 months after diagnosis. This case suggests the importance of hematological examination and, when there is any abnormality which is not caused by GHD, such as pancytopenia, more detailed medical examinations (for example bone marrow examination) are necessary.
Inada
S
S
Department of Pediatrics, Saga Medical School, Japan.
Shida
K
K
Mouri
Y
Y
Sakai
R
R
Koga
H
H
Miyazaki
S
S
Okamura
J
J
Anami
K
K
Eguchi
M
M
D002648:Child; D013006:Growth Hormone / Q000009:adverse effects* / Q000172:deficiency*; D006801:Humans; D007947:Leukemia, Megakaryoblastic, Acute / Q000209:etiology* / Q000503:physiopathology; D008297:Male
D013006:Growth Hormone